8-K
Family Office Of America, Inc. (FOFA)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 30, 2022
QUALIS
INNOVATIONS, INC.
(Exact name of registrant as specified in its charter)
| Nevada | 333-260982 | 84-2488498 |
|---|---|---|
| (State<br> or other jurisdiction<br><br> <br>of<br> incorporation) | (Commission<br><br> <br>File Number) | (IRS<br> Employer<br><br> <br>Identification<br> No.) |
225Wilmington West Chester Pike
Suite200 # 145
ChaddsFord**, Pennsylvania**
19317
(Address of principal executive offices)
Registrant’s telephone number, including area code: Telephone: : (484) 483-2134
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title<br> of each class | Trading<br> Symbol(s) | Name<br> of each exchange on which registered |
|---|---|---|
| There<br> were 8,475,950 shares of common stock $0.001 par value, issued and outstanding as of November 14, 2022 | QLIS | OTC<br> Pink marketplace |
Item5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements ofCertain Officers.
On December 30, 2022, Dr. Joseph V. Pergolizzi, Jr., a member of, and Chairman of, the Board of Directors of Qualis Innovations, Inc. (the “Company”) and the acting Chief Executive Officer of the Company, notified the Company of his decision to resign, effective immediately, from his position as a member of, and Chairman of, the Board of Directors of the Company and from any and all offices he may hold with the Company, including as acting Chief Executive Officer of the Company. Dr. Pergolizzi’s resignation was to pursue other business opportunities and did not result from any disagreement with the Company, the Company’s Board of Directors, or the Company’s management on any matter relating to the Company’s operations, policies or practices.
| Exhibit No | Description |
|---|---|
| 1 | Formal<br> resignation letter for Joseph Pergolizzi as CEO of Qualis and its subsidiaries, submitted to the Qualis<br> Board of Directors on December 30, 2022. |
| 104 | Cover<br> Page Interactive Data File (embedded within the Inline XBRL document) |
| -2- |
| --- |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| QUALIS INNOVATIONS, INC. | ||
|---|---|---|
| Date: | December<br> 30, 2022 | |
| /s/ John Ballard | ||
| John<br> Ballard, Chief Financial Officer |
| -3- |
| --- |
Exhibit 1
